Video & Transcript Research : 'blood tests'

Page 17 of 500
CA

California 2025-2026 Regular Session

Senate Health Committee Mar 25th, 2026

Transcript Highlights:
  • Renee Bayardo representing Blood Cancer United in strong support.
  • We do express some... ...and get some where the testing would be the most effective.
  • We don't have a problem with testing or reporting over certain levels.
  • But they still make them test for the... ...because they don't do gasoline.
  • But they still make them test for the stuff that would be in refineries for gasoline.
Summary: The Senate Committee on Health heard several health-related bills, with extensive public testimony and multiple roll-call votes. SB 895, by Senator Wiener, would create the California Foundation for Science and Health Research and place a bond measure on the November 2026 ballot to support science and health research in California amid federal funding cuts. The author and UC researchers argued the measure would protect jobs, public health, and the state’s research leadership; many universities, labor groups, and patient advocates testified in support, and there was no opposition. The committee members praised the bill, and it passed 6-0 to the Committee on Natural Resources and Water. SB 944, also by Senator Wiener, would make acupuncture a permanent Medi-Cal benefit regardless of federal matching funds. Supporters, including acupuncturists, patients, community organizations, and health access advocates, described acupuncture as effective, low-cost, and culturally important care; there was no opposition. The committee discussed access for API communities and Medi-Cal patients, and the bill passed 6-0 to the Committee on Appropriations. SB 987, by Senator Wiener, would create a California Health Access Fund to capture state savings if federal Medicaid changes cause Medi-Cal enrollment losses, with the goal of redirecting those savings to care for affected patients and providers. Support came from disability, consumer, family physician, emergency physician, psychiatric, medical, and safety-net hospital groups. Committee members discussed prioritizing indigent care, prevention, and other vulnerable populations if savings materialize. The bill passed 8-0 to Appropriations. SB 964, by Senator Smallwood-Cuevas, would limit prior authorization barriers by allowing certain dose or frequency adjustments for covered medications without repeated authorization, up to two clinically appropriate changes. The bill was supported by a Crohn’s and colitis patient and sponsor testimony describing delays in care, while health plans and insurers opposed it over safety, FDA-labeling, and cost concerns. Committee members raised questions about off-label use and clinical standards, but the author said the bill was intended to reduce delays and avoid emergency care; it passed 11-0 to Appropriations. SB 1099, by Senator Reyes, would clarify local governments’ authority to provide state and local public benefits to all residents under PRWORA-related exemptions, to reduce legal uncertainty for local safety-net programs. County counsel and city attorney representatives said the bill would preserve local flexibility to provide services such as health care, shelter, crisis response, and food distribution without unnecessary eligibility barriers; there was no opposition, and the bill passed 11-0 to the Committee on Human Services. SB 1033, by Senator Padilla, would require manufacturers of protein products to test for heavy metals and disclose results. Supporters cited Consumer Reports findings of lead, cadmium, arsenic, and mercury in protein powders and beverages, while opponents asked for narrower scope and raised concerns about naturally occurring metals and over-warning consumers. The committee discussed narrowing the bill and the need for transparency, and it passed 11-0 to the Committee on Environmental Quality. Finally, SB 1049, by Senator Weber-Pearson, would give providers a fair opportunity to correct certain claim errors after a health plan action, rather than being barred by original filing deadlines. An OBGYN testified that a missing diagnostic code led to large clawbacks and delayed payments despite appropriate care; the bill was presented as a limited fix for honest mistakes. The transcript ends during testimony on SB 1049, before a final vote is shown.
CA

California 2025-2026 Regular Session

Senate Health Committee Mar 25th, 2026

Health

Transcript Highlights:
  • Renee Bayardo representing Blood Cancer United in strong support.
  • We do express some... ...and get some where the testing would be the most effective.
  • We don't have a problem with testing or reporting over certain levels.
  • But they still make them test for the stuff that would be in refineries for gasoline.
  • But they still make them test for the stuff that would be in refiners for gasoline.
Keywords: 987, senate, all
TX
Transcript Highlights:
  • Unfortunately, she's older and on blood thinners, and so she had a serious problem.
  • Do you know what the troponin blood test is for? Thank you for asking the questions.
  • Troponin is a blood test that we use to see if heart tissue is dying in real time, which myocarditis
  • tests that we literally rely on.
  • Troponin is the test that if it's elevated, you're not going home.
TX

Texas 89th Regular

Insurance Apr 23rd, 2025

Insurance

Transcript Highlights:
  • Insurance carriers frequently deny claims for necessary tests or surgeries, only acknowledging minor
  • Fortunately, a local blood cancer clinic...
  • Aaron Liss, One Oncology in the Center for Cancer and Blood Disorders in New York.
  • Oncology and the Center for Cancer and Blood Disorders in Texas in support of House Bill 3057.
  • Potentially curative treatment for certain advanced blood cancers.
TX

Texas 89th Regular

Senate Session Mar 27th, 2025

Texas Senate Floor Meeting

Bills: SJR37, SJR57, SCR8, SB8, SB108, SB125, SB251, SB318, SB378, SB379, SB396, SB472, SB487, SB503, SB533, SB565, SB583, SB608, SB650, SB686, SB689, SB707, SB710, SB763, SB854, SB875, SB916, SB924, SB925, SB958, SB961, SB965, SB987, SB988, SB1006, SB1019, SB1021, SB1024, SB1026, SB1038, SB1146, SB1185, SB1194, SB1202, SB1252, SB1253, SB1330, SB1343, SB1362, SB1497, SB1498, SB1499, SB1527, SB1547, SB1596, SB1697, SJR36, SJR12, SJR57, SJR37, SCR22, SCR12, SCR8, SB925, SB1362, SB565, SB765, SB62, SB666, SB707, SB888, SB687, SB847, SB1248, SB504, SB857, SB305, SB296, SB284, SB1497, SB1499, SB1498, SB241, SB304, SB621, SB1023, SB1024, SB686, SB371, SB204, SB609, SB670, SB850, SB854, SB413, SB1346, SB1033, SB1220, SB1073, SB810, SB1539, SB447, SB875, SB406, SB985, SB965, SB1119, SB1505, SB1194, SB1253, SB1215, SB1302, SB856, SB583, SB673, SB681, SB1172, SB1252, SB378, SB608, SB955, SB957, SB988, SB1019, SB1021, SB1120, SB251, SB541, SB379, SB1737, SB266, SB1415, SB1527, SB125, SB599, SB1330, SB53, SB916, SB1352, SB785, SB710, SB472, SB1450, SB1502, SB1566, SB414, SB1062, SB961, SB1038, SB578, SB711, SB746, SB942, SB1404, SB1448, SB1738, SB108, SB8, SB318, SB507, SB533, SB689, SB1026, SB1349, SB1355, SB1433, SB1434, SB1596, SB1403, SB1146, SB763, SB667, SB1059, SB617, SB1567, SB503, SB16, SB310, SB311, SB396, SB505, SB1209, SB1210, SB1470, SB264, SB924, SB1029, SB1185, SB1202, SB1358, SB1364, SB1569, SB1697, SB1376, SB1228, SB519, SB878, SB1350, SB462, SB1535, SB827, SB1585, SB207, SB1207, SB1619, SB1396, SB920, SB1484, SB1273, SB1741, SB7, SB927, SB1227, SB1229, SB1353, SB1366, SB1464, SB1709, SB1729, SB1733, SB1744, SB1772, SB1816, SB1841, SB2188, SB1147, SB879, SB1008
TX

Texas 89th Regular

Press Conference: Senator Sarah Eckhardt Mar 26th, 2025

Texas Senate Floor Meeting

Bills: SJR57, SCR8, SB8, SB14, SB24, SB108, SB112, SB125, SB213, SB251, SB315, SB318, SB371, SB378, SB379, SB472, SB487, SB502, SB513, SB565, SB621, SB650, SB689, SB707, SB710, SB761, SB763, SB815, SB854, SB875, SB896, SB916, SB925, SB958, SB961, SB965, SB973, SB987, SB990, SB995, SB1006, SB1018, SB1019, SB1024, SB1026, SB1146, SB1194, SB1198, SB1253, SB1330, SB1343, SB1362, SB1379, SB1497, SB1498, SB1527, SB1532, SB1547, SB1596, SJR36, SJR12, SJR57, SCR22, SCR12, SCR8, SB565, SB765, SB62, SB666, SB707, SB888, SB687, SB847, SB1248, SB14, SB1006, SB504, SB925, SB995, SB857, SB305, SB296, SB284, SB815, SB1379, SB1497, SB1499, SB1498, SB241, SB304, SB621, SB1023, SB1024, SB686, SB112, SB371, SB204, SB609, SB670, SB502, SB850, SB854, SB413, SB1362, SB1346, SB1033, SB1220, SB1073, SB810, SB987, SB1539, SB447, SB875, SB406, SB985, SB965, SB1119, SB1505, SB24, SB1194, SB1253, SB1215, SB1532, SB1302, SB856, SB650, SB583, SB673, SB213, SB681, SB1172, SB1252, SB378, SB1343, SB608, SB487, SB955, SB957, SB988, SB990, SB1019, SB1021, SB1120, SB251, SB958, SB761, SB541, SB315, SB379, SB1018, SB1737, SB266, SB1415, SB1527, SB125, SB599, SB1330, SB53, SB916, SB896, SB1352, SB973, SB785, SB710, SB472, SB1450, SB1502, SB1566, SB414, SB1062, SB1547, SB961, SB1038, SB513, SB578, SB711, SB746, SB942, SB1404, SB1448, SB1738, SB108, SB8, SB318, SB507, SB533, SB689, SB1026, SB1349, SB1355, SB1433, SB1434, SB1596, SB1403, SB1198, SB1146, SB763, SB667, SB1059, SB617, SB1567, SB503, SJR37, SB16, SB310, SB311, SB396, SB505, SB1209, SB1210, SB1470, SB264, SB924, SB1029, SB1185, SB1202, SB1358, SB1364, SB1569, SB1697, SB1376, SB1228, SB519, SB878, SB1350, SB462, SB1535, SB827, SB1585, SB207, SB1207, SB1619, SB1396, SB920, SB1484, SB1273, SB1741
TX

Texas 89th Regular

Senate Session (Part I) Mar 26th, 2025

Texas Senate Floor Meeting

Transcript Highlights:
  • Today, an individual's DNA can be... shipped, tested, and sold to unauthorized third parties, all within
  • scores, used to predict disease. and intelligence, experts remain wary of the connection between DNA testing
  • all the written records of a school. district concerning their child including attendance records, test
  • forms or survey to a student in addition to the consent required to conduct a assignment. examination, test
  • covered by the critical infrastructure protections that are used for the launch, landing, recovery, or testing
Bills: SJR57, SCR8, SB8, SB14, SB24, SB108, SB112, SB125, SB213, SB251, SB315, SB318, SB371, SB378, SB379, SB472, SB487, SB502, SB513, SB565, SB621, SB650, SB689, SB707, SB710, SB761, SB763, SB815, SB854, SB875, SB896, SB916, SB925, SB958, SB961, SB965, SB973, SB987, SB990, SB995, SB1006, SB1018, SB1019, SB1024, SB1026, SB1146, SB1194, SB1198, SB1253, SB1330, SB1343, SB1362, SB1379, SB1497, SB1498, SB1527, SB1532, SB1547, SB1596, SJR36, SJR12, SJR57, SCR22, SCR12, SCR8, SB565, SB765, SB62, SB666, SB707, SB888, SB687, SB847, SB1248, SB14, SB1006, SB504, SB925, SB995, SB857, SB305, SB296, SB284, SB815, SB1379, SB1497, SB1499, SB1498, SB241, SB304, SB621, SB1023, SB1024, SB686, SB112, SB371, SB204, SB609, SB670, SB502, SB850, SB854, SB413, SB1362, SB1346, SB1033, SB1220, SB1073, SB810, SB987, SB1539, SB447, SB875, SB406, SB985, SB965, SB1119, SB1505, SB24, SB1194, SB1253, SB1215, SB1532, SB1302, SB856, SB650, SB583, SB673, SB213, SB681, SB1172, SB1252, SB378, SB1343, SB608, SB487, SB955, SB957, SB988, SB990, SB1019, SB1021, SB1120, SB251, SB958, SB761, SB541, SB315, SB379, SB1018, SB1737, SB266, SB1415, SB1527, SB125, SB599, SB1330, SB53, SB916, SB896, SB1352, SB973, SB785, SB710, SB472, SB1450, SB1502, SB1566, SB414, SB1062, SB1547, SB961, SB1038, SB513, SB578, SB711, SB746, SB942, SB1404, SB1448, SB1738, SB108, SB8, SB318, SB507, SB533, SB689, SB1026, SB1349, SB1355, SB1433, SB1434, SB1596, SB1403, SB1198, SB1146, SB763, SB667, SB1059, SB617, SB1567, SB503, SJR37, SB16, SB310, SB311, SB396, SB505, SB1209, SB1210, SB1470, SB264, SB924, SB1029, SB1185, SB1202, SB1358, SB1364, SB1569, SB1697, SB1376, SB1228, SB519, SB878, SB1350, SB462, SB1535, SB827, SB1585, SB207, SB1207, SB1619, SB1396, SB920, SB1484, SB1273, SB1741
TX

Texas 89th Regular

Senate Session (Part II) Mar 26th, 2025

Texas Senate Floor Meeting

Bills: SJR57, SCR8, SB8, SB14, SB24, SB108, SB112, SB125, SB213, SB251, SB315, SB318, SB371, SB378, SB379, SB472, SB487, SB502, SB513, SB565, SB621, SB650, SB689, SB707, SB710, SB761, SB763, SB815, SB854, SB875, SB896, SB916, SB925, SB958, SB961, SB965, SB973, SB987, SB990, SB995, SB1006, SB1018, SB1019, SB1024, SB1026, SB1146, SB1194, SB1198, SB1253, SB1330, SB1343, SB1362, SB1379, SB1497, SB1498, SB1527, SB1532, SB1547, SB1596, SJR36, SJR12, SJR57, SCR22, SCR12, SCR8, SB565, SB765, SB62, SB666, SB707, SB888, SB687, SB847, SB1248, SB14, SB1006, SB504, SB925, SB995, SB857, SB305, SB296, SB284, SB815, SB1379, SB1497, SB1499, SB1498, SB241, SB304, SB621, SB1023, SB1024, SB686, SB112, SB371, SB204, SB609, SB670, SB502, SB850, SB854, SB413, SB1362, SB1346, SB1033, SB1220, SB1073, SB810, SB987, SB1539, SB447, SB875, SB406, SB985, SB965, SB1119, SB1505, SB24, SB1194, SB1253, SB1215, SB1532, SB1302, SB856, SB650, SB583, SB673, SB213, SB681, SB1172, SB1252, SB378, SB1343, SB608, SB487, SB955, SB957, SB988, SB990, SB1019, SB1021, SB1120, SB251, SB958, SB761, SB541, SB315, SB379, SB1018, SB1737, SB266, SB1415, SB1527, SB125, SB599, SB1330, SB53, SB916, SB896, SB1352, SB973, SB785, SB710, SB472, SB1450, SB1502, SB1566, SB414, SB1062, SB1547, SB961, SB1038, SB513, SB578, SB711, SB746, SB942, SB1404, SB1448, SB1738, SB108, SB8, SB318, SB507, SB533, SB689, SB1026, SB1349, SB1355, SB1433, SB1434, SB1596, SB1403, SB1198, SB1146, SB763, SB667, SB1059, SB617, SB1567, SB503, SJR37, SB16, SB310, SB311, SB396, SB505, SB1209, SB1210, SB1470, SB264, SB924, SB1029, SB1185, SB1202, SB1358, SB1364, SB1569, SB1697, SB1376, SB1228, SB519, SB878, SB1350, SB462, SB1535, SB827, SB1585, SB207, SB1207, SB1619, SB1396, SB920, SB1484, SB1273, SB1741
MN

Minnesota 2025-2026 Regular Session

Committee on Judiciary and Public Safety - 04/10/26

Judiciary and Public Safety

Transcript Highlights:
  • And I do know for a fact that there is the ability to do blood tests to determine whether someone has
  • And is the ability to test the blood work, is that something that's readily available?
  • blood ability to test the blood uh the blood work,<02:32:32.000><c> is</c><02:32:32.160><c> that</c><
  • a few days of when the blood test was drawn.
  • a few days of when the blood test was drawn.
Keywords: 1187, senate, all
KY
Transcript Highlights:
  • </c> even redefined the scope of the testing. even redefined the scope of the testing.
  • So, this definitely cuts into the two-hour time limit of an officer getting a blood draw. >> A blood
  • </c> there's the 2-hour time limit of blood there's the 2-hour time limit of blood draws.<01:45:31.440
  • There are can get the blood drawn.
  • </c><01:46:48.480><c> of</c> someone like that to draw the blood of someone like that to draw the blood
Keywords: 958, all
Summary: The committee first approved the April 13 minutes and then turned to a large agenda of contracts. Chairman Douglas said there were 52 contracts totaling about $369.3 million, and noted that most vendors were registered with the Secretary of State except for item 118 on the routine personal services green list and item 19 involving Morehead State University and Kentucky State University. The committee voted to defer item 118 to the June 26 meeting and later also deferred the Kentucky State University contract on the deferred list to the June 26 meeting. The main discussion centered on a deferred personal services contract for the Kentucky Board of Optometric Examiners, involving outside legal counsel. Senator Meredith raised concerns about KRS 320 and whether the board had authority to hire outside counsel when the statute says the Attorney General shall provide legal services to the board. Dr. Mary Beth Morris, the board president, and Christopher Thacker of the Attorney General’s office testified after being sworn in. Thacker explained that the statute and related law allow both Attorney General assistance and independent counsel, and argued that outside counsel is appropriate for day-to-day legal work because it avoids conflicts, especially on open records issues, regulatory advice, and disciplinary hearings. Senator Meredith said he agreed with approving the contract but questioned how the board had reached this point and whether the current statutes reflect modern practice. He raised concerns about transparency and accountability, referencing a prior advisory opinion involving the board’s handling of exam requirements during COVID and saying the board should have consulted the Attorney General before acting. Thacker responded that the Attorney General’s office serves the Commonwealth as a whole, not as counsel to one board, and that the board’s use of outside counsel is a reasonable and economical arrangement. The exchange ended with Meredith suggesting that broader legislative action may be needed to clarify reporting relationships and oversight for the board.
MO

Missouri 2026 Regular Session

Substance Abuse Prevention and Treatment Task Force Jun 24th, 2026

Substance Abuse Prevention and Treatment Task Force

Transcript Highlights:
  • Testing, testing. Hello? Hello? Testing, testing. We can hear y'all just fine. Oh, okay. Oh, okay.
  • Testing, testing, these are coming on. Hello, hello? Hey, we have microphone. Good. I'm sorry?
  • Let's check your blood work. Let's support you in healthy decision making.
  • Let's check your blood work. Let's support you in healthy decision making.
  • Just like, you know, just like I take blood, or I used to take blood pressure medicine or, you know,
Summary: The task force meeting opened with a brief organizational update, including new leadership, roll call, and an explanation of the task force’s statutory duties: to study current and future drug and substance use in Missouri, explore solutions, draft or modify legislation, and report recommendations on prevention and treatment. The chair outlined the summer hearing plan, which would feature field experts, with future sessions expected to cover alternative therapies such as psilocybin and ibogaine and testimony from the Department of Mental Health. Members were encouraged to think about legislative ideas and policy recommendations for the upcoming session. The first major testimony came from Dr. Rachel Winograd, who described Missouri’s overdose crisis as evolving into a “fourth wave” marked by fentanyl mixed with animal tranquilizers such as xylazine and medetomidine, along with methamphetamine and other synthetic drugs. She said overdose deaths have declined for a third straight year, with preliminary 2025 data around 1,200 deaths, but emphasized that the crisis remains severe. Her main recommendations were to focus on demand reduction rather than repeated supply crackdowns, expand evidence-based treatment—especially methadone and buprenorphine—broaden naloxone access, and improve practical supports like housing, transportation, and case management. She also said peer services are valuable but should not be used as a substitute for clinical care, and noted that Missouri Medicaid generally covers evidence-based treatment but reimbursement for peer recovery services remains a gap. Dr. Heidi Miller, the state medical director at the Department of Health and Senior Services, reinforced the call for integrating substance use disorder care into whole-person health care. She highlighted the state naloxone standing order, which supports more than 11,000 Medicaid naloxone prescriptions annually, and urged five best practices: integrating SUD treatment into primary care, maternal health, general medical training, EMS initiation of buprenorphine after overdose, and expanded methadone access. She also argued for team-based reimbursement, stronger parity enforcement between behavioral health/SUD and physical health, and caution in regulating emerging substances so policy does not outrun the science. Dr. Doug Burgess of University Health in Kansas City echoed the integration theme, arguing that Missouri’s system is too fragmented and that patients are often stabilized and then left to coordinate their own next steps. He compared ideal SUD care to the coordinated response used for heart attacks, with seamless transitions from emergency care to inpatient treatment, rehab, and outpatient follow-up. He said treatment courts can be effective when they are well coordinated and informed by addiction science, and he stressed the importance of discharge planning, peer recovery coaches, information-sharing, and maintaining Medicaid coverage during justice involvement. No formal votes or committee actions were taken during this portion of the meeting.
TX

Texas 89th Regular

Health and Human Services May 23rd, 2025

Health & Human Services

Transcript Highlights:
  • House Bill 50 ensures that HIV testing is offered as a part of STD screenings unless the patient opts
  • Senator Cook, just a quick question on the STD testing, is everything opt-in?
  • you get tested for HIV or is it just never?
  • Can we send you anywhere else for more testing?'
  • an extremely expensive test to run.
Bills: HB50
MO

Missouri 2026 Regular Session

Emerging Issues Feb 16th, 2026

Emerging Issues and Professional Registration

Transcript Highlights:
  • You do these testing and all this blood work ahead of time.
  • There were blood tests that were happening. There was a physician that was involved.
  • But they see someone that they can use, someone that scores highly on every test they've given them.
  • All the psilocybin has to be tested in a state-licensed laboratory.
  • We have the capacity to cultivate, test, and dispense a safe therapeutic psilocybin. Thank you.
Summary: The committee first met in executive session and voted do pass on House Bill 3037, House Bill 2760, House Bill 1778, and House Bill 2830, each by recorded roll call. HB 3037, HB 2760, and HB 1778 all passed 8-4, while HB 2830 passed unanimously 12-0. The committee also said it would not take up HB 1746 and HB 1769 yet, because more work was needed on an amendment. The public hearing began with House Bill 3005, sponsored by Representative Justice, which would require public and school libraries to adopt and post reconsideration policies for challenged materials, limit requests to local residents or parents/guardians, extend the process to digital materials, and prohibit tracking or retaining personalized user data from digital library resources. Justice said the bill was developed with the Secretary of State’s office and library groups and was intended to add transparency, local control, and privacy protections. Testimony from EBSCO Information Services and the Missouri Library Association supported the bill as a codification of existing library practices and a way to create clearer procedures. The committee then heard a group of similar bills on AI-generated or digitally altered depictions, including measures by Representatives Lucas, Farnan, Gallick, Schmidt, Williams, Houseman, and Dolan. The sponsors described the bills as closing loopholes in child pornography, revenge-porn, and digital impersonation laws, creating civil remedies, criminal penalties, and in some versions platform takedown requirements for nonconsensual altered images. Members raised questions about how to combine the bills, whether sunsets should be included, and how the proposals relate to existing revenge-porn law. No votes were taken on these bills during the hearing. Finally, the committee heard House Bills 2817 and 2961 on ibogaine research for veterans and other trauma-affected populations, followed by House Bills 1717 and 1643 on psilocybin and other alternative therapies. Supporters, including veterans, first responders, clinicians, and family members, described severe PTSD, TBI, addiction, and suicide crises and said these treatments had helped them when conventional care had not. Opponents, including the Missouri State Medical Association, said they did not support non-FDA-approved drugs. Members questioned the cost and structure of the proposed studies, the role of the FDA, and whether similar research is already underway. The hearing ended without a vote on these bills.
TX
Transcript Highlights:
  • This patient was vomiting blood, and the patient was actually taking blood out of their PICC line with
  • Sometimes it's a blood gas, which is a painful prick, but it's not like surgery.
  • You saw the blood run out of their face.
  • There are no lab tests for it, no X-rays for it.
  • And here's the medical testing." My first cases were back in 2006.
KY

Kentucky 2026 Regular Session

House Legislative Session Day 16 (1-29-26)

Kentucky House Floor Meeting

Transcript Highlights:
  • </c> from immunological products, blood from immunological products, blood fractions<00:33:21.360><c>
  • House Bill 525, Representative Holloway, an act relating to vision testing on renewal of operator's license
  • :38:13.920><c> vision</c> Holloway, an act relating to vision Holloway, an act relating to vision testing
  • renewal</c><00:38:15.760><c> of</c><00:38:16.000><c> operator's</c><00:38:16.560><c> license</c> testing
  • on renewal of operator's license testing on renewal of operator's license and<00:38:17.280><c> declaring
FL

Florida 2026 Regular Session

Fiscal Policy Feb 18th, 2026

Fiscal Policy

Transcript Highlights:
  • Normally, red blood cells are disc-shaped and flexible, allowing them to move easily through blood vessels
  • In sickle cell disease, red blood cells are misshaped, typically crescent or sickle-shaped, due to a
  • When red blood cells sickle, they do not bend or move easily and can block blood flow to the rest of
  • According to the National Heart, Lung, and Blood Institute, 100,000 people in the United States and 8
  • I am requesting that you support this bill because, one, it is the most common genetic blood disorder
Summary: The Fiscal Policy Committee met and first reported favorably SB 774, which extends enhanced workers’ compensation benefits to 9-1-1 public safety telecommunicators for mental or nervous injuries, after adopting a late-filed amendment declaring an important state interest. The committee also heard supportive testimony from a Palm Beach County dispatcher. SB 770, which updates the definition of forensic clients so certain individuals with intellectual disabilities or autism can be housed with other Chapter 916 residents in secure forensic settings, was reported favorably as well. Members then approved CS/SB 86, which declares unauthorized operation of a commercial vehicle by an unauthorized alien an imminent safety hazard and imposes driver, carrier, and enforcement consequences, despite questions about vehicle impoundment and cargo handling and one appearance in opposition. SB 1594, which protects veterans’ benefits received on behalf of foster youth from being used as reimbursement and instead sets them aside for education and transition services, was reported favorably after supportive testimony. The committee also approved CS/SB 760, creating a new offense for willful violations of no-contact pretrial release conditions in certain violent crime cases, though the Florida Association of Criminal Defense Lawyers raised concerns about expanded warrantless arrest authority in one section. The committee next reported favorably CS/SB 554, a complete rewrite of Chapter 617 governing nonprofit corporations, after a technical delete-all amendment. It also approved CS/SB 844, requiring continuing education on sickle cell disease care for certain health care professionals; the bill drew extensive supportive testimony from advocates and patients describing pain management gaps and health disparities. SB 1022, expanding Florida Children’s Initiatives by adding programs in Bay County and Broward County, and CS/SB 1246, broadening the Linking Industry to Nursing Education Fund to include health science workforce programs and related uses, were both reported favorably. Finally, the committee approved CS/CS/SB 1230, which restricts the use, sale, and distribution of aqueous film-forming foam containing intentionally added PFAS and requires inventory and disposal reporting, after adopting amendments that removed airports from one provision. It also approved CS/CS/SB 128, directing DEP to erect markers for the Andrew Red Harris Spoil Island water body designation. Several senators requested to be recorded as voting in the affirmative on specific bills, and the committee adjourned without objection.
FL

Florida 2026 Regular Session

Fiscal Policy Feb 18th, 2026

Fiscal Policy

Transcript Highlights:
  • Normally, red blood cells are disc-shaped and flexible, allowing them to move easily through blood vessels
  • In sickle cell disease, red blood cells are misshaped, typically crescent or sickle-shaped, due to a
  • When red blood cells sickle, they do not bend or move easily and can block blood flow to the rest of
  • According to the National Heart, Lung, and Blood Institute, 100,000 people in the United States...
  • According to the National Heart, Lung, and Blood Institute, 100,000 people in the United States and 8
Keywords: 999, senate, all
TX

Texas 89th Regular

Health and Human Services Apr 30th, 2025

Health & Human Services

Transcript Highlights:
  • And this patient was vomiting blood, and the patient was actually taking blood out of their PICC line
  • Sometimes it’s a blood gas, which is a painful prick, but it’s not like surgery.
  • No lab test for it, no X-ray for it. No lab test for it. No X-ray for it.
  • And each time I do see that those doctors did a test and they verified and they do it.
  • Hearing none, it is so ordered. tested calendar. Is there objection?
Summary: The committee met with a quorum and announced it would vote on pending bills at 10:30, with public testimony limited to two minutes. It first took up Senate Bill 905, a TDLR cleanup bill on licensing regulation of speech-language pathologists and audiologists. Senator Zafferini said the committee substitute would streamline advisory board consultation, remove obsolete provisional licenses, and allow any licensed physician to authorize hearing instruments for minors; the substitute was adopted and the bill left pending. The committee then heard House Bill 451, which would require universal screening for commercial sexual exploitation risk for children in DFPS conservatorship and youth under TJJD jurisdiction. The author and witnesses from Children at Risk, the Fort Bend Anti-Trafficking Collective, and Texas CASA supported the bill as a prevention tool with existing infrastructure and training; the committee adopted the substitute and left the bill pending. The committee next considered Senate Bill 466, which would clarify that families may request a fetal death certificate at any gestational age, while keeping existing filing requirements for physicians. A constituent father testified about losing his 11-week-old daughter and being told he could not obtain a certificate, which he said prevented funeral arrangements; the substitute was adopted and the bill left pending. Senate Bill 2311 followed, requiring residential treatment centers to have a written agreement with the school that will educate resident children before becoming operational. The author cited a local dispute where an RTC and school district lacked communication, and witnesses from Texas CASA and Disability Rights Texas supported clearer educational planning while suggesting the Education Code may need conforming changes; the bill was left pending. The committee then heard Senate Bill 2826, known as Alyssa’s Law, which would create a statewide education program on medical child abuse for medical students, health care professionals, and CPS caseworkers. The author and Sheriff Bill Weyburn described Alyssa’s case as involving repeated unnecessary surgeries and argued the bill would improve awareness and early identification, while several witnesses and members raised concerns about false accusations, impacts on medically fragile children, and the need for scientific, peer-reviewed training and safeguards. After extensive discussion, the chair left the bill pending. The committee also heard House Bill 136, which would add certified lactation consultants as Medicaid providers to expand breastfeeding support; witnesses from lactation and nutrition fields said the bill would improve access, maternal and infant health, and long-term savings, and the bill was left pending. Finally, the committee took up Senate Bill 2805, a surprise-billing/arbitration measure that would clarify provider identifiers and shift arbitration costs to the losing party. The author said the substitute was a legislative counsel draft with no substantive difference, and witnesses from the Texas Medical Association, Texas Society of Anesthesiologists, and U.S. Anesthesia Partners supported the bill as a modest improvement that would reduce administrative confusion and make arbitration fairer without weakening patient protections. Members discussed how arbitration costs affect settlement behavior and how to define the “winner” in close cases. The bill was heard but not voted out during this segment.
WA

Washington 2025-2026 Regular Session

House Health Care & Wellness Jan 20th, 2026

Transcript Highlights:
  • A federal court recently acknowledged that HHS may have the authority to test a rebate model, but that
  • H.B. 2145 fails that test.
  • liquid part of the blood, often for payment.
  • blood components for a plasma source donation center.
  • or blood components, returning blood cells to the donor during apheresis, obtaining the informed consent
Summary: The committee first heard House Bill 2437, which would put the Department of Health’s authority to accredit opioid treatment programs into statute and allow the department to set a fee to cover the cost of those services. The prime sponsor and DOH said the bill would preserve a service that is especially important to tribal and rural providers and would be self-sustaining rather than supported by the general fund. Members asked about the relationship between DOH and HCA and whether the bill would duplicate existing authority; staff and the department said DOH already performs the accrediting role and the bill mainly formalizes that authority and fee-setting power. Public testimony on the bill was then closed. The committee then held an extensive work session on the federal 340B drug pricing program and later opened public testimony on House Bill 2145, which would prohibit manufacturers, distributors, and third-party logistics providers from restricting 340B drug acquisition or delivery and from requiring claims or utilization data as a condition of access. Committee staff and NCSL gave background on how 340B works, recent growth in the program, contract pharmacy issues, and state efforts in other jurisdictions. Testimony on HB 2145 was sharply divided: hospitals, community health centers, tribal representatives, contract pharmacies, and labor groups said the bill would protect safety-net providers, rural access, HIV and behavioral health services, and tribal programs from manufacturer restrictions; business groups, pharmaceutical companies, and employer coalitions argued the program has expanded beyond its original intent, lacks transparency, shifts costs to employers and taxpayers, and should be addressed through federal reform instead. No vote was taken in the excerpt. Finally, the committee heard House Bill 2155, which would bar non-human entities from using nursing titles such as RN, APRN, or LPN or otherwise implying they are licensed nurses. The prime sponsor said the bill is intended to protect patients from being misled by AI systems and to preserve transparency and public safety as health care technology expands. The Washington State Nurses Association testified in support, saying AI can be useful but should not replace nurses or be presented as a licensed professional. A member asked about enforcement and liability, and staff said they would follow up on those details.
MO

Missouri 2026 Regular Session

Health and Mental Health Feb 19th, 2026

Health and Mental Health

Transcript Highlights:
  • Well, there is the test that’s commonly used, and that’s the Ig blood serum test.
  • Well, there is the test that's commonly used, and that's the IG blood serum test.
  • So that test that's run by that lab is already... ...test.
  • So you're not tested just because we're random testing every high school senior.
  • Blood pressure drops, blood sugar stabilizes, weight decreases, energy increases,...
Summary: The committee first met in executive session and voted House Bill 2309, Representative Jones’ Oregon Harvesting bill, do pass by a vote of 13 ayes and no nays. The committee then moved to public testimony on House Bill 1881, which would schedule xylazine as a controlled substance. Representative Bill Allen said the bill is intended to address xylazine’s role in fentanyl-related overdoses, improve tracking and enforcement, and preserve legitimate veterinary use through carve-outs. A veterinarian from the University of Missouri testified in support, emphasizing xylazine’s long-standing and safe veterinary use and the need to protect agricultural practice while targeting illicit diversion. No opposition was presented, and testimony on the bill concluded. The committee then heard House Bill 1855, which would add alpha-gal syndrome to Missouri’s reportable conditions and create a reporting/surveillance framework. Sponsor Representative Matthew Overcast said the bill was revised to shift reporting from providers to private labs, create a standalone non-communicable disease reporting section, and support data collection for prevalence, education, and federal funding opportunities. Supporters included a lobbyist for the AlphaGal Alliance, a University of Missouri dermatologist/researcher, Extension staff, cattle industry representatives, and multiple patients and family members who described severe dietary restrictions, anxiety, school and work impacts, and the need for better public awareness and treatment research. Opponents argued the bill’s language would expand DHSS authority too broadly, especially the provision allowing the department to designate and enforce rules for noncommunicable diseases, and suggested narrowing the bill and adding opt-in protections. No vote was taken. Finally, the committee began hearing House Bill 2355, Representative Holly Jones’ “food as medicine” bill. Jones argued that nutrition should be treated as a public health intervention and described medically tailored meals, produce prescriptions, and nutrition counseling as tools that can improve outcomes and reduce costs. In questions, members raised concerns about how the proposal would interact with existing food assistance programs such as SNAP, WIC, school meals, and other federal nutrition benefits, and whether the bill would create a new entitlement or duplicate existing aid. The hearing on HB 2355 was still in progress when the transcript ended.